View all trials
Are you a member? Sign in above to view additional information
  • Study title
    A clinical trial of donor-derived WT1 specific T cells for prevention of relapse in combination with multiple pathogen specific T cells for prevention of infection in patients undergoing allogeneic haemopoietic stem cell transplant for acute myeloid leukaemia
  • Protocol ID
    INTACT-WT1
  • Disease
    Disease Type Disease Subtype
    Leukaemia
    AML
  • Eligibility criteria
  • Study Status
    Open
  • Location(s)
    Children's Hospital at Westmead
    • Centre Study Status:
      Open
    • Notes:
  • Phase
    Phase 1
  • Study type
    Treatment
  • Diagnosis stage
    Relapse/refractory
  • Study open date
    01/03/2017
  • Study close date
    N/A
  • Study chair
  • Sponsor
    Western Sydney Local Health District (WSLHD)
Back to search results